C12N 5/064
Immunosuppressive dendritic cells
Official title: {Immunosuppressive dendritic cells}
C12N5/064 (Immunosuppressive dendritic cells) appears on 70 US grants and 159 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 159
- Assignees
- 104
- Inventors
- 330
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 2 |
| 2002 | 0 | 3 |
| 2003 | 0 | 4 |
| 2004 | 0 | 8 |
| 2005 | 1 | 7 |
| 2006 | 0 | 14 |
| 2007 | 1 | 4 |
| 2008 | 1 | 5 |
| 2009 | 4 | 7 |
| 2010 | 6 | 13 |
| 2011 | 3 | 6 |
| 2012 | 6 | 9 |
| 2013 | 4 | 10 |
| 2014 | 6 | 4 |
| 2015 | 1 | 9 |
| 2016 | 7 | 9 |
| 2017 | 3 | 5 |
| 2018 | 6 | 5 |
| 2019 | 4 | 9 |
| 2020 | 2 | 7 |
| 2021 | 3 | 4 |
| 2022 | 1 | 7 |
| 2023 | 2 | 3 |
| 2024 | 3 | 3 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tolerogenic antigen presenting cells24 Mar 2026US 12,582,706 B2Cell4Cure AB
- Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases17 Jun 2025US 12,329,807 B2MegaNano Biotech, Inc.
- NF-KB signaling pathway-manipulated dendritic cells26 Nov 2024US 12,152,247 B2Friedrich-Alexander-Universität Erlangen-Nürnberg
- Expansion of NK and DC cells in vivo mediating immune response18 Jun 2024US 12,011,460 B2Universite de Montreal
- Manipulated immunoregulatory element and immunity altered thereby18 Jun 2024US 12,012,598 B2Toolgen Incorporated
- Methods of Formulating a Vaccine9 Apr 2026US 2026/0097104 A1MegaNano Biotech, Inc.
- Selective tolerization - methods of selectively generating tolerogenic dendritic cells11 Dec 2025US 2025/0375477 A1Transimmune AG
- Manipulated immunoregulatory element and immunity altered thereby12 Sep 2024US 2024/0301424 A1Toolgen Incorporated
- Preparation method of citrullinated vimentin antigen-specific immune tolerogenic dendritic cells, and uses thereof11 Jul 2024US 2024/0226150 A9Daegu Gyeongbuk Institute of Science and Technology
- Preparation method of citrullinated vimentin antigen-specific immune tolerogenic dendritic cells, and uses thereof25 Apr 2024US 2024/0131061 A1Daegu Gyeongbuk Institute of Science and Technology
Most cited
By later US patents
- Culturing monocytes with IL-4, TNF-.alpha. and GM-CSF TO induce differentiation to dendric cells86US 5,849,589 ADuke University · 1998
- Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications38US 6,165,785 AShriners Hospitals for Children · 2000
- Method for producing dendritic cells23US 7,247,480 B2Isis Innovation Limited · 2007
- Method of regulating dendritic cell maturation11US 5,871,728 AUniversity of Pittsburgh · 1999
- Therapeutical composition containing dentritic cells and use thereof11US 8,415,152 B2Helmholtz-Zentrum FüR Infektionsforschung GmbH · 2013